| |
Many life sciences organizations are faced with the promise of great discoveries and the challenges of market fluctuations and increasing regulation. For pharmaceutical, biotechnology, medical products, and technology and device companies, the life sciences industry is changing at an unprecedented rate. |
| |
|
| |
These organizations face a host of issues:
| |
|
 |
The impact of managed care, new therapeutic discoveries, revolution in research and development and drug discovery, securing patents and intellectual property protection, evolution of the biotech sector, |
|
| |
|
Emergence of the specialty and generic sectors, |
|
| |
|
Access to capital, royalty and revenue recovery, mergers and acquisitions, shifting markets and sources, |
|
| |
|
Worldwide efforts to control health care costs |
|
| |
|
An evolving regulatory and compliance environment |
|
| |
With extensive domain knowledge and thorough technical expertise, complete answers are ensured to every customer's needs.
|
| |
| Influx's approach is to offer solutions that are comprehensive, integrated and future-proofed and provide you with the capabilities for sales and operations planning, quality management, recipe and batch management, and supply chain operations. As well as support profit reporting along with integrated services that let you unify process control systems and monitor production execution. We continually incorporate and build upon industry best practices, where we will with a proven method implement and deliver support services for an enterprise resource planning solution - perfect for midsize companies and large enterprises with subsidiaries. With the industry best practices for Pharmaceuticals you benefit from: |
| |
|
|
Electronic signature and audit trails. |
|
| |
|
Electronic batch recording. |
|
| |
|
Unit management and recipe management. |
|
| |
|
A process operations cockpit for monitoring production execution. |
|
| |
|
Automated process for master data approval. |
|
| |
|
|
|
| |
Influx support Addresses Challenges associated with New Product Launch by Life Sciences Company. |
|
| |
|
|
| |
Providing Competitive Advantage and Accelerating New Product Launches |
|
| |
Life Sciences executives are realizing that supply-chain improvement can not only lead to significant increases in shareholder |
|
| |
|
|
| |
Two Key Strategies |
|
| |
Influx works with clients to develop client-specific supply-chain opportunities spanning management consulting through systems integration. Our supply-chain solution focuses on two industry-leading strategies: |
|
| |
. |
|
| |
Internal Efficiency through Operations Excellence |
|
| |
Manufacturing and Quality (M&Q) organizations within global life sciences companies must become excellent at what they do. Our Operations Excellence solution focuses on the improvement of M&Q operations by aligning organizations/departments with business processes, pulled by customer demand. We have consistently achieved benefits for our life sciences clients in risk reduction, cycle time reduction, waste elimination and document handling. |
|
| |
|
|
| |
External Effectiveness through Commercial Transformation |
|
| |
Pharmaceutical manufacturers must tackle their order-to-cash processes to maximize their revenue and minimize the cost of fulfilling demand. Influx's commercial transformation methodology has been developed specifically for the pharmaceutical industry, to increase the value of the margin between cost-of-goods and selling price to the patient, and to develop trade relationships and transform the supply chain. |
|
| |
|
|
| |
A Full Spectrum of Solutions |
|
| |
In addition, we offer general supply-chain solutions to support clients in the full spectrum of their supply-chain issues including: |
|
| |
|
|
| |
|
Collaborative sourcing. |
|
|
| |
|
|
| |
|
Transportation and logistics. |
|
|
| |
|
|
| |
|
Demand planning. |
|
|
| |
|
|
| |
|
Price revenue optimization. |
|
|
| |
|
|
| |
|
Contract management. |
|
|
|
